We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

Back to rankings

48 hedge funds and large institutions have $219M invested in Translate Bio, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 9

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

41% more funds holding

Funds holding: 34 → 48 (+14)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less capital invested

Capital invested by funds: $227M → $219M (-$8.24M)

Holders
48
Holders Change
+14
Holders Change %
+41.18%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
10
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
+$53.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.35M
3
BlackRock
BlackRock
New York
+$3.22M
4
Wells Fargo
Wells Fargo
California
+$1.9M
5
SFM
Sphera Funds Management
Israel
+$1.71M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$8.22M
2
Citigroup
Citigroup
New York
-$6.62M
3
ACH
ArrowMark Colorado Holdings
Colorado
-$3.75M
4
BCPEM
Bain Capital Public Equity Management
Massachusetts
-$2.75M
5
LM
Luminus Management
Texas
-$1.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
KSCM
51
Key Square Capital Management
Connecticut
– -$696K -55,000 Closed
DIM
52
DC Investments Management
Virginia
– -$659K -52,084 Closed
PCM
53
Pentwater Capital Management
Florida
– -$380K -30,000 Closed
SSA
54
Schonfeld Strategic Advisors
New York
– -$253K -20,000 Closed
SM
55
Sabby Management
Florida
– -$152K -12,000 Closed
PHK
56
Point72 Hong Kong
Hong Kong
– -$128K -10,128 Closed
CGI
57
CI Global Investments
California
– -$84K -7,000 Closed
1 2
3

TBIO Hedge Fund Activity: Q3 2018 in Review

48 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q3 2018, worth a combined $219M — down 3.6% from $227M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new TBIO positions and 9 closed out — a net gain of 14 holders — while 10 added to existing stakes and 7 trimmed.

The largest buyer was Baupost Group, adding an estimated $53.2M. The largest seller was Deerfield Management, exiting entirely with an estimated $8.22M sold.

  • 48 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q3 2018, up from 34 in Q2 2018.
  • Funds reported $219M of Translate Bio, Inc. Common Stock stock for Q3 2018, down 3.6% quarter-over-quarter.
  • 23 funds opened new Translate Bio, Inc. Common Stock positions in Q3 2018 and 9 closed out, a net change of +14 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q3 2018 was Baupost Group, an estimated $53.2M added.
  • The largest Translate Bio, Inc. Common Stock seller in Q3 2018 was Deerfield Management, an estimated $8.22M sold.

Based on aggregated 13F filings for Q3 2018.